PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3605877-6 1987 Some of the new cephalosporins of the third generation (cefotaxime and ceftriaxone) and cefuroxime have a good activity in vitro and a good passage to the CSF. Cefotaxime 56-66 colony stimulating factor 2 Homo sapiens 155-158 2689353-14 1989 CSF penetration of cefotaxime was evaluated in seven patients: concentrations ranged from 0.499 mg/l to 2.829 mg/l. Cefotaxime 19-29 colony stimulating factor 2 Homo sapiens 0-3 2963304-6 1987 Mean CSF concentrations of cefotaxime, desacetylcefotaxime and fosfomycin on the 2nd and 15th days of treatment were 4, 3.5 and 39.8 mg/l and 2.2, 2.1 and 28.0 mg/l, respectively. Cefotaxime 27-37 colony stimulating factor 2 Homo sapiens 5-8 6276458-4 1982 Nine concentrations of cefotaxime in lumbar and ventricular CSF out of 19 in a group of seven neurosurgical patients with mild to moderate impairment of the blood-CSF-barrier were higher than 0.5 micrograms/ml. Cefotaxime 23-33 colony stimulating factor 2 Homo sapiens 60-63 6094430-2 1984 The CSF concentrations of cefotaxime fluctuated around 4 mg/l. Cefotaxime 26-36 colony stimulating factor 2 Homo sapiens 4-7 6094452-3 1984 Three hours after the end of the infusion, mean CSF concentrations of cefotaxime and fosfomycin were respectively at day 2 3.2 mg/l and 31.4 mg/l, at day 4 2.9 mg/l and 33.9 mg/l. Cefotaxime 70-80 colony stimulating factor 2 Homo sapiens 48-51 6330021-3 1984 Mean concentration of cefotaxime in CSF ranged from 0.8 mg/l (aseptic meningitis), to 6.4 mg/l (Gram-negative and listeria meningitis), and from 0.5 to 5.4 mg/l for the metabolite. Cefotaxime 22-32 colony stimulating factor 2 Homo sapiens 36-39 6311128-5 1983 Trough CSF levels of cefotaxime (range, 5.6 to 44.3 micrograms/mL) and desacetylcefotaxime (3.7 to 44.0 micrograms/mL) were manyfold greater than the minimal bactericidal concentrations of the causative pathogens with the exception of the one Pseudomonas aeruginosa isolate. Cefotaxime 21-31 colony stimulating factor 2 Homo sapiens 7-10 6288338-2 1982 All isolated micro-organisms were highly sensitive to it in serial dilution, except for one case, and were quickly removed from blood and CSF by the administration of cefotaxim alone. Cefotaxime 167-176 colony stimulating factor 2 Homo sapiens 138-141 6288338-4 1982 Thus cefotaxim has a high antibacterial activity and satisfactory CSF passage in purulent meningitis caused by sensitive, especially gram-negative, bacteria and is well suitable for therapy, if penicillins alone or combined are not applicable or effective. Cefotaxime 5-14 colony stimulating factor 2 Homo sapiens 66-69 6269429-4 1981 The newer cephalosporins or cehalosporin-type antibiotics (cefotaxime, moxalactam), by virtue of their marked activity against gram-negative bacilli and their ability to achieve significant CSF levels, merit serious consideration as therapy for gram-negative bacillary meningitis. Cefotaxime 59-69 colony stimulating factor 2 Homo sapiens 190-193 7654271-2 1994 The authors recommend an initial antimicrobial regimen associating cefotaxime or ceftriaxone to vancomycin in any case of bacterial meningitis in which S pneumoniae appears to be involved (Gram positive cocci on direct examination of the CSF and/or presence of soluble bacterial antigen). Cefotaxime 67-77 colony stimulating factor 2 Homo sapiens 238-241 9303415-1 1997 Cerebrospinal fluid (CSF) was taken from 19 children with bacterial meningitis treated with cefotaxime (300 mg/kg of body weight/day) and vancomycin (60 mg/kg/day). Cefotaxime 92-102 colony stimulating factor 2 Homo sapiens 0-25 9303415-2 1997 Median levels of drugs in CSF were smaller than expected, as follows: 4.4 microg/ml for cefotaxime, 3.2 microg/ml for desacetylcefotaxime, and 1.7 microg/ml for vancomycin. Cefotaxime 88-98 colony stimulating factor 2 Homo sapiens 26-29 9303415-3 1997 The median CSF bactericidal titer against an intermediately cefotaxime-resistant pneumococcus was 1:4. Cefotaxime 60-70 colony stimulating factor 2 Homo sapiens 11-14 6259596-0 1981 [Cefotaxime CSF levels in children with purulent meningitis (author"s transl)]. Cefotaxime 1-11 colony stimulating factor 2 Homo sapiens 12-15 6259609-5 1981 Because cefotaxime is active at low concentration and has a good diffusion in the CSF, it provides a particularly effective treatment in Gram-negative meningitis in children. Cefotaxime 8-18 colony stimulating factor 2 Homo sapiens 82-85 6101414-5 1980 CSF levels were measured in seven children and ranged from 300 to 27 200 microgram/l; published and unpublished in-vitro studies suggest that minimum inhibitory concentrations for cefotaxime against the organisms commonly causing bacterial meningitis are usually well below 250 microgram/l. Cefotaxime 180-190 colony stimulating factor 2 Homo sapiens 0-3 2091255-2 1990 Review of recent data from the USA and Europe indicates that delayed CSF sterilization occurs significantly more often with ampicillin/chloramphenicol and cefuroxime than with ceftriaxone and cefotaxime. Cefotaxime 192-202 colony stimulating factor 2 Homo sapiens 69-72